Sativex (THC+CBD) and oral THC alone produced similar effects at therapeutic doses, with no evidence CBD reduced THC side effects
In 9 cannabis smokers, Sativex and equivalent oral THC doses produced similar, mild increases in heart rate and anxiety, with no evidence that CBD in Sativex attenuated THC's effects at therapeutic doses.
Quick Facts
What This Study Found
Nine cannabis smokers received five treatments in randomized, double-blind fashion: placebo, low and high doses of oral synthetic THC, and low and high doses of Sativex (1:1 THC:CBD oromucosal spray).
At therapeutic doses, Sativex and oral THC produced similar, clinically insignificant increases in heart rate, anxiety, and "good drug effects." No serious adverse events occurred with either treatment.
Contrary to the hypothesis that CBD would attenuate THC-induced side effects, no substantial CBD-induced modulation of THC's effects was evident at these dose levels. Oral and oromucosal THC delivery had slower absorption and lower brain delivery rates compared to smoked cannabis, resulting in fewer adverse events.
The authors concluded that Sativex had a safety profile comparable to oral THC at low, therapeutic doses.
Key Numbers
9 participants. Sativex low: 5.4 mg THC + 5.0 mg CBD. Sativex high: 16.2 mg THC + 15.0 mg CBD. Oral THC: 5 and 15 mg. Similar effects across equivalent THC-dose conditions. No serious adverse events.
How They Did This
Randomized, double-blind, placebo-controlled, five-session crossover study in 9 cannabis smokers. Treatments: placebo, 5 and 15 mg oral THC, low-dose Sativex (5.4 mg THC + 5.0 mg CBD), high-dose Sativex (16.2 mg THC + 15.0 mg CBD). Pharmacodynamic assessments over 10.5 hours.
Why This Research Matters
The finding that CBD did not noticeably reduce THC effects at therapeutic doses challenged a key marketing claim about Sativex and had implications for how combination products were understood and prescribed.
The Bigger Picture
This study contributed to the ongoing debate about whether CBD meaningfully modifies THC effects in pharmaceutical products, an important question for clinical cannabinoid development.
What This Study Doesn't Tell Us
Very small sample (9 participants). Cannabis smokers may have different sensitivity than naive users. Only therapeutic doses tested; CBD modulation might emerge at higher doses. Single-dose sessions only.
Questions This Raises
- ?Does CBD modulate THC effects at higher doses or with chronic administration?
- ?Is the similar safety profile sufficient to justify Sativex over pure oral THC?
Trust & Context
- Key Stat:
- No CBD-induced modulation of THC effects at therapeutic doses
- Evidence Grade:
- Randomized, double-blind crossover study with appropriate controls but very small sample size (9 participants).
- Study Age:
- Published in 2011. The question of CBD-THC interaction continues to be studied.
- Original Title:
- Subjective and physiological effects after controlled Sativex and oral THC administration.
- Published In:
- Clinical pharmacology and therapeutics, 89(3), 400-7 (2011)
- Authors:
- Karschner, E L, Darwin, W D, McMahon, R P, Liu, F, Wright, S, Goodwin, R S, Huestis, M A
- Database ID:
- RTHC-00493
Evidence Hierarchy
Participants are randomly assigned to treatment or placebo groups to test cause and effect.
What do these levels mean? →Frequently Asked Questions
Does CBD in Sativex reduce THC side effects?
At the therapeutic doses tested in this study, CBD did not noticeably reduce THC's effects on heart rate, anxiety, or subjective drug effects. Sativex and pure oral THC had similar safety profiles.
Is Sativex safer than pure THC?
At these doses, Sativex and oral THC produced similar, mild effects. Both were safer than smoked cannabis due to slower absorption and lower peak brain delivery of THC.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-00493APA
Karschner, E L; Darwin, W D; McMahon, R P; Liu, F; Wright, S; Goodwin, R S; Huestis, M A. (2011). Subjective and physiological effects after controlled Sativex and oral THC administration.. Clinical pharmacology and therapeutics, 89(3), 400-7. https://doi.org/10.1038/clpt.2010.318
MLA
Karschner, E L, et al. "Subjective and physiological effects after controlled Sativex and oral THC administration.." Clinical pharmacology and therapeutics, 2011. https://doi.org/10.1038/clpt.2010.318
RethinkTHC
RethinkTHC Research Database. "Subjective and physiological effects after controlled Sative..." RTHC-00493. Retrieved from https://rethinkthc.com/research/karschner-2011-subjective-and-physiological-effects
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.